A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures
This study is ongoing, but not recruiting participants.
Eisai Co., Ltd.
First Posted: June 13, 2012
Last Update Posted: August 22, 2017
Information provided by (Responsible Party):
Eisai Inc. ( Eisai Co., Ltd. )
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||September 2019|
|Primary Completion Date:||September 15, 2014 (Final data collection date for primary outcome measure)|